Molecular diagnostics · Medical device development
From the molecular laboratory to medical devices.
White Coat Sciences began in 2020 as a CLIA high-complexity molecular laboratory during the COVID-19 response. What started as a laboratory has expanded into medical device development, with molecular diagnostics still at the center of the work.
- Founded 2020
- Founders Drs. Brent and Anna Harris
- Capabilities Molecular diagnostics and device development
- Headquarters Carrollton, Georgia
What we do
Three pillars
Our work is organized around three commitments, each built on the discipline of a clinical molecular laboratory.
-
Diagnose with excellence
Molecular diagnostics is where White Coat Sciences began and remains a core capability. Laboratory rigor shapes every program we take on.
-
Design devices that matter
We design medical devices around real clinical workflows, starting with how specimens are collected, handled, and brought to the laboratory.
-
Develop pharmacologic solutions
We apply the same scientific discipline to pharmacologic development, advancing work carefully and only as the evidence supports.
Pipeline
Programs
VagiGuard is a Class I medical device being released soon. The other programs are under development.
Work with White Coat Sciences
We welcome conversations with clinicians, laboratory and industry partners, and the press. Choose the form that fits your inquiry. Please do not send health information, results, or medical records.